Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-16-469890
Filing Date
2016-02-19
Accepted
2016-02-19 15:17:03
Documents
68
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d126077d10k.htm 10-K 874024
2 EX-10.36 d126077dex1036.htm EX-10.36 174294
3 EX-23.1 d126077dex231.htm EX-23.1 1566
4 EX-31.1 d126077dex311.htm EX-31.1 9268
5 EX-31.2 d126077dex312.htm EX-31.2 9163
6 EX-32.1 d126077dex321.htm EX-32.1 5217
13 GRAPHIC g126077g37j13.jpg GRAPHIC 62250
  Complete submission text file 0001193125-16-469890.txt   5991696

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT hrtx-20151231.xml EX-101.INS 1368140
8 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20151231.xsd EX-101.SCH 48778
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrtx-20151231_cal.xml EX-101.CAL 41929
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrtx-20151231_def.xml EX-101.DEF 354649
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20151231_lab.xml EX-101.LAB 338575
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20151231_pre.xml EX-101.PRE 380916
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33221 | Film No.: 161441613
SIC: 2834 Pharmaceutical Preparations